AD is characterized by mutations in PSEN1/2, which lead to the augmentation of the opening of mitochondrial permeability transition pore (mPTP) Ca2+-releasing channels, producing an extreme statement of Ca2+ from this store [92,93]. This evidence concerns the gene PSEN1 and Alzheimer disease.